GC has been shown to increase the level of P-glycoprotein (P-gp)/multi-drug resistance type 1 (MDR1) in brain endothelial cells [180] and in lymphocytes of patients with rheumatoid arthritis [179], which may lead to drug resistance in patients with autoimmune diseases [179,181]. Here, ABCB1 is linked to rheumatoid arthritis.